Literature DB >> 30259183

Genetics of Dilated Cardiomyopathy.

Yiwen Fu1, Howard J Eisen2.   

Abstract

PURPOSE OF REVIEW: Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and systolic function and is the most common among all cardiomyopathies. Familial DCM makes up a significant portion of cases, and approximately 40 genes are identified as involved in the pathogenesis of heart failure, each affecting a specific part of cellular mechanisms. The purpose of this review is to summarize recent findings and the current understanding of the most common gene mutations identified associated with DCM. RECENT
FINDINGS: Next-generation sequencing is a comprehensive gene analysis technique used to discover more mutation variants and also to learn about the impact of mutations in relationship to clinical presentations. A variety of techniques are utilized to study different gene mutations, such as genotype-phenotype association analysis or whole-exome sequencing, to understand the natural history of diseases. For certain genetic abnormalities, information is helpful in developing potential therapeutic treatment targeting mutations. More treatment options are hopeful with the understanding of specific genetic mutations and their pathogenic mechanism. It also suggests the importance of genetic assessment and counseling for family members of an affected patient, in order to provide potential early diagnosis and better clinical management of DCM.

Entities:  

Keywords:  Dilated cardiomyopathy; Familial; Gene mutations; Lamin A/C; Screening; Titin

Mesh:

Substances:

Year:  2018        PMID: 30259183     DOI: 10.1007/s11886-018-1061-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  32 in total

Review 1.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.

Authors:  Biykem Bozkurt; Monica Colvin; Jennifer Cook; Leslie T Cooper; Anita Deswal; Gregg C Fonarow; Gary S Francis; Daniel Lenihan; Eldrin F Lewis; Dennis M McNamara; Elfriede Pahl; Ramachandran S Vasan; Kumudha Ramasubbu; Kismet Rasmusson; Jeffrey A Towbin; Clyde Yancy
Journal:  Circulation       Date:  2016-11-03       Impact factor: 29.690

2.  A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.

Authors:  Guan-Sheng Liu; Ana Morales; Elizabeth Vafiadaki; Chi Keung Lam; Wen-Feng Cai; Kobra Haghighi; George Adly; Ray E Hershberger; Evangelia G Kranias
Journal:  Cardiovasc Res       Date:  2015-04-07       Impact factor: 10.787

3.  Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.

Authors:  Nadine Norton; Duanxiang Li; Mark J Rieder; Jill D Siegfried; Evadnie Rampersaud; Stephan Züchner; Steve Mangos; Jorge Gonzalez-Quintana; Libin Wang; Sean McGee; Jochen Reiser; Eden Martin; Deborah A Nickerson; Ray E Hershberger
Journal:  Am J Hum Genet       Date:  2011-02-25       Impact factor: 11.025

4.  High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation.

Authors:  H M Bécane; G Bonne; S Varnous; A Muchir; V Ortega; E H Hammouda; J A Urtizberea; T Lavergne; M Fardeau; B Eymard; S Weber; K Schwartz; D Duboc
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

5.  Relevance of truncating titin mutations in dilated cardiomyopathy.

Authors:  O Akinrinade; T-P Alastalo; J W Koskenvuo
Journal:  Clin Genet       Date:  2016-02-19       Impact factor: 4.438

6.  Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy.

Authors:  Roberta Roncarati; Chiara Viviani Anselmi; Peter Krawitz; Giovanna Lattanzi; Yskert von Kodolitsch; Andreas Perrot; Elisa di Pasquale; Laura Papa; Paola Portararo; Marta Columbaro; Alberto Forni; Giuseppe Faggian; Gianluigi Condorelli; Peter N Robinson
Journal:  Eur J Hum Genet       Date:  2013-03-06       Impact factor: 4.246

Review 7.  Current insights into LMNA cardiomyopathies: Existing models and missing LINCs.

Authors:  Daniel Brayson; Catherine M Shanahan
Journal:  Nucleus       Date:  2017-01-02       Impact factor: 4.197

8.  Truncations of titin causing dilated cardiomyopathy.

Authors:  Daniel S Herman; Lien Lam; Matthew R G Taylor; Libin Wang; Polakit Teekakirikul; Danos Christodoulou; Lauren Conner; Steven R DePalma; Barbara McDonough; Elizabeth Sparks; Debbie Lin Teodorescu; Allison L Cirino; Nicholas R Banner; Dudley J Pennell; Sharon Graw; Marco Merlo; Andrea Di Lenarda; Gianfranco Sinagra; J Martijn Bos; Michael J Ackerman; Richard N Mitchell; Charles E Murry; Neal K Lakdawala; Carolyn Y Ho; Paul J R Barton; Stuart A Cook; Luisa Mestroni; J G Seidman; Christine E Seidman
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

9.  Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?

Authors:  Despina Sanoudou; Fotis Kolokathis; Demetris Arvanitis; Kholoud Al-Shafai; Navaneethakrishnan Krishnamoorthy; Rachel J Buchan; Roddy Walsh; Dimitris Tsiapras; Paul Jr Barton; Stuart A Cook; Dimitrios Kremastinos; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2015-07-03

Review 10.  Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy.

Authors:  Ali M Tabish; Valerio Azzimato; Aris Alexiadis; Byambajav Buyandelger; Ralph Knöll
Journal:  Biophys Rev       Date:  2017-05-05
View more
  10 in total

1.  Retrospective Study of Intercalated Disk Defects Associated with Dilated Cardiomyopathy, Atrial Thrombosis, and Heart Failure in BALB/c Mice Deficient in IL4 Receptor α.

Authors:  Alfonso S Gozalo; Patricia M Zerfas; William R Elkins; Richard L Gieseck
Journal:  Comp Med       Date:  2020-05-08       Impact factor: 0.982

Review 2.  Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model.

Authors:  Karen R Gaar-Humphreys; Talitha C F Spanjersberg; Giorgia Santarelli; Guy C M Grinwis; Viktor Szatmári; Bernard A J Roelen; Aryan Vink; J Peter van Tintelen; Folkert W Asselbergs; Hille Fieten; Magdalena Harakalova; Frank G van Steenbeek
Journal:  Animals (Basel)       Date:  2022-06-29       Impact factor: 3.231

3.  Young and early-onset dilated cardiomyopathy with malignant ventricular arrhythmia and sudden cardiac death induced by the heterozygous LDB3, MYH6, and SYNE1 missense mutations.

Authors:  Ting Zhao; Yuting Ma; Zuoquan Zhang; Jianzhong Xian; Xiaojing Geng; Feng Wang; Jiana Huang; Zhe Yang; Yi Luo; Yubi Lin
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-05-05       Impact factor: 1.468

4.  Screening for mutations in human cardiomyopathy- is RBM24 a new but rare disease gene?

Authors:  Anna Gaertner; Andreas Brodehl; Hendrik Milting
Journal:  Protein Cell       Date:  2019-06       Impact factor: 14.870

5.  Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yayun Weng; Shuo Zhang; Wei Huang; Xianze Xie; Zhiyuan Ma; Qiaomei Fan
Journal:  Biomed Res Int       Date:  2021-01-12       Impact factor: 3.411

6.  Rare and potential pathogenic mutations of LMNA and LAMA4 associated with familial arrhythmogenic right ventricular cardiomyopathy/dysplasia with right ventricular heart failure, cerebral thromboembolism and hereditary electrocardiogram abnormality.

Authors:  Jia Chen; Yuting Ma; Hong Li; Zhuo Lin; Zhe Yang; Qin Zhang; Feng Wang; Yanping Lin; Zebing Ye; Yubi Lin
Journal:  Orphanet J Rare Dis       Date:  2022-05-07       Impact factor: 4.123

7.  A novel causative functional mutation in GATA6 gene is responsible for familial dilated cardiomyopathy as supported by in silico functional analysis.

Authors:  Afrouz Khazamipour; Nazanin Gholampour-Faroji; Tina Zeraati; Farveh Vakilian; Aliakbar Haddad-Mashadrizeh; Majid Ghayour Mobarhan; Alireza Pasdar
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

8.  Personalized Medicine Approach in a DCM Patient with LMNA Mutation Reveals Dysregulation of mTOR Signaling.

Authors:  Balram Neupane; Kabita Pradhan; Audrey Magdalena Ortega-Ramirez; Parwez Aidery; Vytautas Kucikas; Matthias Marks; Marc A M J van Zandvoort; Karin Klingel; Klaus K Witte; Stefan Gründer; Nikolaus Marx; Michael Gramlich
Journal:  J Pers Med       Date:  2022-07-15

Review 9.  An Omics View of Emery-Dreifuss Muscular Dystrophy.

Authors:  Nicolas Vignier; Antoine Muchir
Journal:  J Pers Med       Date:  2020-06-15

Review 10.  Big Data Approaches in Heart Failure Research.

Authors:  Jan D Lanzer; Florian Leuschner; Rafael Kramann; Rebecca T Levinson; Julio Saez-Rodriguez
Journal:  Curr Heart Fail Rep       Date:  2020-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.